Peptide Therapeutics Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2023-28

1
Global Peptide Therapeutics Market Research and
Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Peptide Therapeutics Market Research
Report The latest report by IMARC, titled
Peptide Therapeutics Market Global Industry
Trends, Share, Size, Growth, Opportunity and
Forecast 2023-2028 " the global peptide
therapeutics market reached a value of US 39.2
Billion in 2022. Peptides refer to naturally
occurring, short chains of amino acid monomers
that are connected with cell surface receptors
for triggering intracellular effects. They are
extremely small, versatile, and offer higher
efficacy than other clinical practices
therefore, they are extensively used for
engineering novel regenerative medications as
they can target varying cells and manipulate
their reactions. Along with this, peptide
therapeutics are non-toxic, well-tolerated, and
offer anti-inflammatory properties, which help in
improving the immune system, repairing muscle
tendons, and acting as an antioxidant for
treating several metabolic disorders.
Consequently, they are being employed for
managing cancer, injuries, aesthetic concerns,
and multiple infectious diseases. Request Free
Sample Report https//www.imarcgroup.com/peptide-
therapeutics-market/requestsample
4
Report Description and Highlights
Report Description

Global Peptide Therapeutics Market Trends With
the increasing prevalence of various chronic and
metabolic disorders, especially amongst the
geriatric population, there has been a rising
need for effective medications, which in turn,
has facilitated the widespread adoption of
peptide therapeutics across the healthcare sector
for treatment purposes. Additionally, the rising
consciousness amongst consumers regarding their
physical appearance has supplemented the
utilization of peptide therapeutics in
cosmeceutical surgeries as they slow down the
aging process, which is acting as another
growth-inducing factor. In line with this,
extensive investments being made by governments
of several countries in pharmaceutical companies
to develop innovative novel peptide medications
and synthetic strategies to improve product
stability are contributing to the market growth.
Moreover, escalating awareness amongst
individuals regarding the availability of
personalized medicines and the ongoing clinical
trials by healthcare professionals to develop and
execute precise non-invasive treatment procedures
to treat autoimmune and inflammatory diseases are
impelling the market growth. Other factors, such
as the significant expansion in the healthcare
infrastructure and continuous research and
development (RD) activities to engineer
multi-purpose peptide-based materials, are
creating a positive outlook for the market. On
account of the aforementioned factors, the market
is anticipated to reach a value of US 66.1
Billion by 2028, growing at a CAGR of 9 during
2023-2028. Looking forward, the market value is
projected to reach a strong growth during the
forecast period (2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Type Innov
ative Generic Breakup by Type of Manufa
cturer Outsourced In-house B
reakup by Synthesis Technology
Solid Phase Peptide Synthesis
Liquid Phase Peptide Synthesis
Hybrid Technology Breakup by Routes of
Administration Parenteral Ora
l Others

6
Report Description and Highlights
Report Description
Breakup by Application
Gastrointestinal Disorders Neurological
Disorders Metabolic Disorders
Cancer Others Breakup by Region
North America United States
Canada Asia-Pacific
China Japan
India South Korea
Australia Indo
nesia Others

7
Report Description and Highlights
Report Description
Europe Germany
France United Kingdom
Italy Spain
Russia Others
Latin America Brazil
Mexico Others
Middle East and Africa

8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Amgen Inc
• Apitope International NV Arch Biopartners Inc. As
  traZeneca plc Circle Pharma Inc. Corden Pharma Gmb
  H F. Hoffmann-La Roche AG Ipsen Group Lonza Group
  AG Novo Nordisk A/S Pfizer Inc. Teva Pharmaceutica
  ls Industries Ltd. Zealand Pharma A/S
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/peptide-therapeutics-ma
  rket

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us